Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder

Pankaj Wadhwa1, Anil K Goswami, Kusum Joshi

  • 1Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

Insights

Cyclooxygenase-2 (COX-2) is highly expressed in bladder cancer, with increased expression correlating significantly with higher tumor grade and stage. This suggests COX-2 may play a role in bladder cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) show anti-cancer effects in experimental models by increasing apoptosis, inhibiting angiogenesis, and reducing metastasis.
  • Cyclooxygenase-2 (COX-2), a mediator of inflammation, is implicated in cancer angiogenesis.

Purpose of the Study:

  • To investigate the expression of cyclooxygenase-2 (COX-2) in bladder cancer tissue specimens.
  • To correlate COX-2 expression levels with tumor grade and depth of invasion (T stage).

Main Methods:

  • Immunohistochemistry was used to evaluate COX-2 expression in bladder cancer tissues.
  • Immunoreactivity for COX-2 was scored from 0 to 3.
  • Statistical analysis was performed to correlate COX-2 expression with tumor grade and T stage.

Main Results:

  • COX-2 immuno-positivity was observed in 84.2% of the 38 bladder cancer patients studied.
  • COX-2 expression intensity significantly correlated with advancing tumor T stage (p=0.01987).
  • A statistically significant correlation was found between COX-2 expression and tumor grade (p=0.05).

Conclusions:

  • The degree of COX-2 expression is significantly elevated in bladder cancer.
  • Increased COX-2 expression is associated with higher tumor grade and advanced T stage.
  • These findings suggest a role for COX-2 in bladder cancer progression.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...